5th Annual Pediatric Cancer Symposium

Milwaukee, WI US
May 10, 2018

The activity provides an exceptional group of nationally and internationally-recognized experts in the field who will gather in Milwaukee to share the latest data for immunotherapy research and its relation to pediatric solid tumors.

Target Audience

Pediatricians, Family Practice Physicians, Nurse Practitioners and Physician Assistants.

Learning Objectives

The learner will be able to understand the rationale and circumstances for providing novel immunotherapy treatment options for their patients who have malignant disorders.

Additional information

CME Coordinator Contact Information

Name: 
Claire Connelly
Phone Number: 
+1 (414) 266-6242
Course summary
Available credit: 
  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
04/09/2018
Course expires: 
07/20/2018
Event starts: 
05/10/2018 - 8:30am
Event ends: 
05/10/2018 - 5:00pm
Cost:
$0.00

Agenda | Thursday, May 10
 
8:30 a.m. Registration and breakfast
 
9:00 a.m. Welcome by Robert Lane, MD | Children’s Hospital of Wisconsin
 
9:05 a.m. Overview of topic by Cindy Schwartz, MD, MPH | Children’s Hospital of Wisconsin
 
9:15 a.m. NK Therapy for Neuroblastoma: What's Done and What's to Come by Katharine Hsu, MD, PhD | Memorial Sloan Kettering Cancer Center
 
10 a.m. Engineering Lymphocytes for the Adoptive Immunotherapy of Solid Tumors by Stephen Gottschalk, MD | St. Jude Children's Research Hospital
 
10:45 a.m. Break and poster viewing
 
11:15 a.m. Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX (CAIX) in Solid Tumors by Shoukat Dedhar, PhD | University of British Columbia
 
12 p.m. Lunch 
 
1 p.m. New Approaches to Treat Pediatric Cancers: Cell-Based Therapies and Beyond by Mario Otto, MD, PhD | University of Wisconsin - Madison 
 
1:45 p.m. Cancer-Specific Mutations Targeted with Receptor-Engineered T Cells by Hans Schreiber, MD, PhD | The University of Chicago
 
2:30 p.m. Break

2:45 p.m. Novel Immunotherapy in Pediatric Solid Tumors by Mitchell Cairo, MD | New York Medical College
 
 

Miller Park
1 Brewers Way
SKYY Lounge
Milwaukee, WI 53214
United States

Planning Committee:
Cindy Schwartz, MD, MPH

Subramaniam Malarkannan, PhD

Monica Thakar, MD

Speakers:

Katharine Hsu, MD, PhD

Stephen Gottschalk, MD

Shoukat Dedhar, PhD

Mario Otto, MD, PhD

Hans Schreiber, MD, PhD

Mitchell Cairo, MD

All persons in control of content have NO relevant financial relationships to disclose except the following person(s):

Name

Company

Role

Shoukat Dedhar, MD

Welichem Biotechnology, Inc.

Scientific consultant
Mitchell Cairo, MD

Jazz

Jazz

Jannsen

Speaker

Advisory Board

Advisory Board

Stephen Gottschalk, MD

TESSA Therapeutics

Immatics

Research collaboration

DSMB

Mario Otto, MD, PhDPatents related to use of radiolabeled Alkyl Phosphocholine AnologsPatent Holder

In accordance with the ACME Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Medical College of Wisconsin designates this activity for up to 4.5 hours of participation for continuing education for allied health professionals.

Available Credit

  • 4.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 4.50 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
04/09/2018
Course expires: 
07/20/2018

Price

Cost:
$0.00
Please login or register to take this course.